Related Experiment Videos
Atherosclerosis: an infectious disease?
1University of Maryland School of Medicine, Baltimore, USA.
Hospital Practice (1995)
|July 21, 2000
Summary
Infectious pathogens like Helicobacter pylori may contribute to atherosclerosis, a condition where arteries harden. Research suggests specific antibiotic treatments could impact outcomes in managing this cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Infectious Disease
- Pathology
Background:
- Traditional risk factors inadequately explain the development of atherosclerosis.
- Emerging evidence implicates infectious agents in the atherosclerotic cascade.
Purpose of the Study:
- To explore the role of infectious pathogens in atherogenesis.
- To investigate potential mechanisms linking infection to atherosclerosis.
- To assess the impact of antibiotic therapy on outcomes.
Main Methods:
- Review of existing evidence on pathogens and atherosclerosis.
- Analysis of proposed pathogenetic mechanisms.
- Consideration of clinical implications of antibiotic interventions.
Main Results:
- Identified Helicobacter pylori, cytomegalovirus, and Chlamydia pneumoniae as potential contributors.
- Highlighted mechanisms including macrophage transformation, endothelial injury, inflammation, and thrombosis.
- Suggested a potential role for antibiotic therapy in managing atherosclerosis.
Conclusions:
- Infectious pathogens represent a significant, yet often overlooked, factor in atherogenesis.
- Understanding these infectious links may reveal novel therapeutic strategies.
- Targeting specific pathogens with antibiotics could be a viable approach to managing atherosclerotic disease.